Andrew A. Krakauer is Chairman at Teleflex, Inc. since 2026 and Independent Director at KL Acquisition Corp. since 2021. Formerly, Mr. Krakauer was Chief Executive Officer & Director at Cantel Medical LLC from 2014 to 2016, President & Chief Executive Officer at Medivators, Inc., and President-Ohmeda Medical Division at Instrumentarium Oyj and GE Healthcare Ltd. (United Kingdom) from 1998 to 2004. Mr. Krakauer earned an MBA from The University of Chicago and completed undergraduate studies at the State University of New York at Binghamton.
Stuart Allen Randle
Stuart Allen Randle is currently Director at Teleflex, Inc. since 2026, Director at Comera Life Sciences, Inc., Lead Independent Director at Comera Life Sciences Holdings, Inc. since 2022, and Trustee at Cotting School. Former roles include President, Chief Executive Officer & Director at ACT Medical, Inc. from 1998 to 2001; Chief Executive Officer at Optobionics Corp. from 2003 to 2004; President, Chief Executive Officer & Director at Ivenix, Inc. from 2015 to 2018; Non-Executive Chairman at QXO Building Products, Inc. from 2023 to 2025; Director at Specialized Health Products International, Inc. from 2001 to 2008; Executive Director at Morphic Medical, Inc. in 2014; Lead Independent Director at Flex Pharma, Inc. from 2014 to 2019; Director at Advanced Medical Technology Association; President-New England Region at Baxter Healthcare Corp.; Vice President at Allegiance Healthcare Corp.; Advisor at Echelon Ventures; and Advisor at Cutlass Capital LLC. Education includes undergraduate studies at Cornell University and an MBA from Kellogg School of Management.
Candace H. Duncan
Candace H. Duncan is an Independent Director at Teleflex, Inc. since 2015. Formerly, served as an Independent Director at Discover Financial Services from 2014 to 2025, an Independent Director at GUE Liquidation Cos., Inc. from 2014 to 2019, and as Director & Managing Partner at KPMG LLP from 2009 to 2013. Educated at Kansas State University with an undergraduate degree.
旧服务已下线，请迁移至 http://api.fanyi.baidu.com
Gretchen R. Haggerty
Gretchen R. Haggerty currently serves as Director at Johnson Controls, Inc., Independent Director at Teleflex, Inc. since 2016, Director at Duquesne Club, Director at Strategic Investment Fund, Inc., Director at The United Way of Southwestern Pennsylvania, Independent Director at Johnson Controls International Plc since 2018, Independent Director at Atmus Filtration Technologies, Inc. since 2022, Member of Financial Executives International, and Member of Allegheny County Bar Association. Former positions include Independent Director at USG Corp. from 2011 to 2019, Director at Highmark, Inc., Treasurer & Director at Pennsylvania Business Council, Director at The United Way of Allegheny County, Treasurer & Vice President at Marathon Oil Corp. from 1991 to 2013, Chief Financial Officer & Executive Vice President at United States Steel & Carnegie Pension Fund, Inc. from 2003 to 2013, and Chief Financial Officer & Executive Vice President at United States Steel Corp. from 2003 to 2013. Education includes undergraduate studies at Case Western Reserve University and graduate studies at Duquesne University of The Holy Spirit.
Andrew A. Krakauer
Andrew A. Krakauer is Chairman at Teleflex, Inc. since 2026 and Independent Director at KL Acquisition Corp. since 2021. Formerly, Mr. Krakauer was Chief Executive Officer & Director at Cantel Medical LLC from 2014 to 2016, President & Chief Executive Officer at Medivators, Inc., and President-Ohmeda Medical Division at Instrumentarium Oyj and GE Healthcare Ltd. (United Kingdom) from 1998 to 2004. Mr. Krakauer earned an MBA from The University of Chicago and completed undergraduate studies at the State University of New York at Binghamton.
John C. Heinmiller
Neena M. Patil
Neena M. Patil is currently Independent Director at Teleflex, Inc. since 2022. Ms. Patil is Director at mothers2mothers. Ms. Patil is Director at Princeton Medical Center Foundation since 2015. Ms. Patil is Chief Legal Officer & Executive Vice President at Jazz Pharmaceuticals, Inc. since 2019. Ms. Patil is Chief Legal Officer & Executive Vice President at Jazz Pharmaceuticals Plc since 2022. Formerly, Ms. Patil was Secretary, General Counsel & Senior Vice President at Abeona Therapeutics, Inc. from 2018 to 2019. Ms. Patil was VP-Legal Affairs & Associate General Counsel at Novo Nordisk, Inc. from 2008 to 2016. Education includes a graduate degree from the University of Michigan conferred in 1999 and an undergraduate degree from Georgetown University conferred in 1996.
Jaewon Ryu
Dr. Jaewon Ryu, MD, is a Chief Executive Officer at Risant Health, Inc., an Independent Director at Teleflex, Inc., an Independent Director at Privia Health Group, Inc., an Advisor at Arboretum Ventures LLC, a President at Geisinger Medical Center and a President & Chief Executive Officer at Geisinger Health Plan. He is on the Board of Directors at Teleflex, Inc., PH Group Parent Corp., Privia Health Group, Inc. and My Health Direct, Inc. Dr. Ryu was previously employed as a Chief Executive Officer by Geisinger Health, a President & Chief Executive Officer by Geisinger Clinic, a President-Integrated Care Delivery by Humana, Inc., an Associate Medical Director by Kaiser Permanente, Inc., a President by Continucare Corp., and a Corporate Healthcare Attorney by McDermott Will & Emery LLP. He received his undergraduate degree from Yale University, a graduate degree from The University of Chicago Law School, a graduate degree from The University of Chicago and a doctorate degree from Pritzker School of Medicine.
Michael Joseph Tokich
Michael Joseph Tokich currently works at Black Diamond Video, Inc., as Chief Executive Officer & Director, American Sterilizer Co., as Chief Executive Officer, STERIS SAS, as Chairman from 2014, STERIS Solutions Ltd., as Director from 2002, STERIS Ltd., as Chief Financial Officer & Director from 2008, Synergy Health Ltd., as Director, Albert Browne Ltd., as Director from 2004, Eschmann Holdings Ltd., as Director from 2014, Mettler-Toledo International, Inc., as Independent Director from 2026, Synergy Health Holdings Ltd., as Director from 2016, Shiloh Ltd., as Director from 2016, Synergy Health Sterilisation UK Ltd., as Director from 2016, STERIS CH Ltd., as Director, Synergy Health (UK) Ltd., as Director from 2016, Synergy Health Investments Ltd., as Director from 2016, STERIS Deutschland GmbH, as Co-Managing Director, STERIS UK Holding Ltd., as Director from 2014, Synergy Sterilisation (M) Sdn. Bhd., as Director, Synergy Health Systems Ltd., as Director, Teleflex, Inc., as Independent Director from 2026, Diagmed Healthcare Ltd., as Director from 2019, Herotron E-Beam Service GmbH, as Co-Managing Director from 2018, Medisafe UK Ltd., as Director from 2016, STE UK HoldCo Ltd., as Director from 2017, STERIS Dover Ltd., as Director from 2018, STERIS Corp., as Chief Financial Officer & Senior Vice President from 2017, and STERIS Instrument Management Services, Inc., as President. Mr. Tokich also formerly worked at Synergy Health US Holdings Ltd., as Director, Varex Imaging Corp., as Director, Phoenix Surgical Holdings Ltd., as Director, OfficeMax LLC, as Division Vice President in 2000, STERIS Plc (Ireland), as Chief Financial Officer & Senior Vice President from 2017 to 2025, and Cantel Medical LLC, as President. Mr. Tokich received his undergraduate degree from Kent State University (Ohio).
Jason Weidman
Jason Weidman is President, Chief Executive Officer & Director at Teleflex, Inc. since 2026. Formerly, Mr. Weidman was Senior VP, President-Coronary & Renal Denervation at Medtronic Plc from 2020 to 2026. Education includes undergraduate studies at the University of Michigan, an MBA from The Wharton School of the University of Pennsylvania, and graduate studies at Stanford University.
提供，免责声明：天汇财经、Factset及其他信息供应商努力确保所提供信息的准确性和可靠性，但对于其正确性或可靠性则不予担保，且对于因不正确或疏漏所造成的任何损失或损坏概不负责(无论是有关民事过失、合同或其他方面)。